Form D · Pharmaceuticals

NBO Pharma Inc.

Bedford, NY · CIK 0002103906

Offering snapshot reported Nov 9, 2026 · SEC filing

Reported sold
$238K
Offering amount: $7M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 2, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2026Initial$238,000No comparison5SEC filing
Jan 22, 2026Initial$7,640,217No comparison93SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$960K
Finders' fees
$0
Form D file number
021-604113
Issuer will provide placement agent (i) 13% of gross proceeds received from qualifying investors, (ii) a $50,000 expense fee, and (iii) 15% PA warrant coverage. Commissions estimate assumes full $7MM offering amount is sold to qualifying investors.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Paulson Investment Company, LLC5670

Source: Form D, filed Nov 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Colin Foster Director
Robert Friedman Director
Bard Geesaman Director
Fredric David Price Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
64 Quarry Lane
Bedford, NY, 10506